** Shares of Argent BioPharma RGT.AX rise 24.1% to A$0.180
** Drug discovery firm says it has entered a strategic manufacturing partnership with ECCPharm
** Under the deal, ECCPharm will manufacture and batch release co’s cannabinoid therapies
** Trade vols at 3x the 30-day avg of 33,207 shares
** RGT up 5.9% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.